Eleanor Wilson

6PUBLICATIONS
5CO-AUTHORS
Medical infection agents (incl. prions)Disease surveillancePredictive and prognostic markersInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2025
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years.

Jaya Goswami, Jose F Cardona, Jorge Caso

|Jun 04, 2025
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.

Erick F Mayer, Ann R Falsey, Rebecca Clark

|Sep 28, 2021
Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis.

Jennifer Wellington, Andrew Ma, Shyam Kottilil

|Dec 18, 2018
Multitarget Direct-Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus.

Shikha Shrivastava, Manasa Bhatta, Haley Ward

|May 31, 2018
Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy.

Ameer Abutaleb, Shyam Kottilil, Eleanor Wilson

Pageof 1

Frequent Collaborators

1 joint publications

Shyam Kottilil

1 joint publications

Erick F Mayer

1 joint publications

Ann R Falsey

1 joint publications

Frances Priddy